Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Chemours (CC) over the last 11 years, with Q3 2025 value amounting to $6.0 million.

  • Chemours' Exchange Rate Effect fell 4000.0% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of -$22.0 million for FY2024, which is 65000.0% down from last year.
  • According to the latest figures from Q3 2025, Chemours' Exchange Rate Effect is $6.0 million, which was down 4000.0% from $15.0 million recorded in Q2 2025.
  • In the past 5 years, Chemours' Exchange Rate Effect registered a high of $31.0 million during Q4 2022, and its lowest value of -$32.0 million during Q3 2022.
  • Its 5-year average for Exchange Rate Effect is -$3.0 million, with a median of -$4.0 million in 2023.
  • In the last 5 years, Chemours' Exchange Rate Effect tumbled by 37500.0% in 2022 and then soared by 47500.0% in 2025.
  • Quarter analysis of 5 years shows Chemours' Exchange Rate Effect stood at -$15.0 million in 2021, then skyrocketed by 306.67% to $31.0 million in 2022, then plummeted by 58.06% to $13.0 million in 2023, then plummeted by 246.15% to -$19.0 million in 2024, then soared by 131.58% to $6.0 million in 2025.
  • Its Exchange Rate Effect was $6.0 million in Q3 2025, compared to $15.0 million in Q2 2025 and $6.0 million in Q1 2025.